ThromboAblation in Acute Myocardial Infarction

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 31, 2008

Study Completion Date

January 31, 2010

Conditions
ST Elevation Acute Myocardial Infarction
Interventions
DEVICE

Laser Thromboablation

Laser Thromboablation using the Spectranetics CVX-300® excimer laser system

DEVICE

PTCA (Direct Stenting)

Balloon predilatation or Direct Stenting using conventional techniques according to local standards and device specific instructions for use

Trial Locations (5)

40-635

Gornoslaskie Centrum Medyczne 3rd Dept of Cardiology, Katowice

31-202

Jagiellonian University College of Medicine, Institute of Cardiology John Paul II Hospital, Krakow

31-501

Department of Haemodynamics and Angiocardiography Medical College Jagiellonian University University Hospital in Krakow, Krakow

61-848

University Hospital No. 1 1st Dept. of Cardiology, Poznan

04-628

Institute of Cardiology Hemodynamics dept., Cardiac Catheterization Laboratory, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Spectranetics Corporation

INDUSTRY

lead

KCRI

OTHER

NCT00650975 - ThromboAblation in Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter